BMS-639432

• CAT Number: I004611
• CAS Number: 1204222-85-4
• Molecular Formula: C21H25ClO7
• Molecular Weight: 424.87
• Purity: ≥95%
• Synonyms: BMS-639432; BMS 639432; BMS639432; UNII-4Q4V69OR2P; 4Q4V69OR2P; SCHEMBL1552187.;(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)-hydroxymethyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
• Solubility: Soluble in DMSO, not in water
• Storage: 0 - 4 °C for short term or -20 °C for long term
• IUPAC Name: (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)-hydroxymethyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
• InChI: InChI=1S/C21H25ClO7/c1-2-28-13-6-3-11(4-7-13)17(24)14-9-12(5-8-15(14)22)21-20(27)19(26)18(25)16(10-23)29-21/h3-9,16-21,23-27H,2,10H2,1H3/t16-,17?,18-,19+,20-,21+/m1/s1
• InChIKey: CUYACVYWMLAWJY-KPMIJUJFSA-N
• SMILES: CCOC1=CC=C(C=C1)C(C2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl)O

BMS-639432 (Cat.No:I004611), also known as a Factor XIa (FXIa) inhibitor, is a small molecule drug developed for the treatment and prevention of thrombosis. It works by inhibiting the activity of Factor XIa, which is a key enzyme in the coagulation cascade. BMS-639432 has shown promising results in preclinical studies and is currently being evaluated in clinical trials for its safety and efficacy in thrombotic disorders.